Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)

PURPOSE: To explore the outcome and prognostic factors between inv(16) and t(8;21) disrupt core binding factor (CBF) in acute myeloid leukemia (AML). METHODS: The clinical characteristic, probability of achieving complete remission (CR), overall survival (OS) and cumulative incidence of relapse (CIR...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Kun-yin, Liao, Xiong-yu, Li, Yang, Huang, Ke, Xu, Hong-gui, Fang, Jian-pei, Zhou, Dun-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210276/
https://www.ncbi.nlm.nih.gov/pubmed/37231380
http://dx.doi.org/10.1186/s12885-023-10965-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210276/
https://www.ncbi.nlm.nih.gov/pubmed/37231380
http://dx.doi.org/10.1186/s12885-023-10965-5

Ejemplares similares